Semaglutide – 20mg

Semaglutide is a synthetic GLP-1 receptor agonist widely studied in
metabolic research for its effects on appetite regulation, glucose control,
and body weight management. As a long-acting peptide, Semaglutide mimics
the activity of endogenous GLP-1, making it a critical compound in obesity
and type 2 diabetes research. The 20mg vial provides a medium-range dosage
option for extended laboratory investigations.

Potential Research Benefits

• Explored for appetite regulation & weight reduction
• Studied for glucose metabolism & insulin sensitivity
• Supports lipid regulation studies
• Long-acting GLP-1 receptor agonist

Scientific Background

Semaglutide functions by binding to and activating the GLP-1 receptor,
which plays a central role in appetite, gastric emptying, and insulin secretion.
Research has shown that GLP-1 agonists can reduce food intake, improve
glycemic control, and support metabolic health. As one of the most studied
GLP-1 analogs, Semaglutide continues to be a cornerstone compound in
obesity and diabetes-related research.

Product Details

• Compound: Semaglutide
• Form: Lyophilized Powder
• Amount: 20mg per vial
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption